EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 47 / No 1 (March 2015) J Extra Corpor Technol, 47 1 (2015) 16-28 References
Free Access
Review
Issue
J Extra Corpor Technol
Volume 47, Number 1, March 2015
Page(s) 16 - 28
DOI https://doi.org/10.1051/ject/201547016
Published online 15 March 2015
  1. Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol. 2008;3:844–861. [CrossRef] [PubMed] [Google Scholar]
  2. Brown JR, Kramer RS, Coca SG, Parikh CR. Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg. 2010;90:1142–1149. [CrossRef] [Google Scholar]
  3. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19–32. [CrossRef] [PubMed] [Google Scholar]
  4. Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009;119:2444–2453. [CrossRef] [PubMed] [Google Scholar]
  5. Bihorac A, Yavas S, Subbiah S, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009;249:851–858. [CrossRef] [PubMed] [Google Scholar]
  6. Smith M, Saunders R, Stuckhardt L, McGinnis JM, eds. Committee on the Learning Health Care System in America; Institute of Medicine. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, DC: Institute of Medicine of the National Academies; 2012:50. [Google Scholar]
  7. Roy AK, McGorrian C, Treacy C, et al. A comparison of traditional and novel definitions (RIFLE, AKIN, and KIDGO) of acute kidney injury of the prediction of outcomes in acute decompensated heart failure. Cardiorenal Med. 2013;3:26–37. [CrossRef] [PubMed] [Google Scholar]
  8. Shann KG, Likosky DS, Murkin JM, et al. An evidence based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg. 2006;132:283–290. [CrossRef] [Google Scholar]
  9. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Inter. 2012;2 (Suppl):1–138. [CrossRef] [Google Scholar]
  10. Tolpin DA, Collard CD, Lee VV, et al. Subclinical changes in serum creatinine and mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2012;143:682–688. [CrossRef] [Google Scholar]
  11. Brown JR, Cochran RP, Leavitt BJ, et al. Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation. 2007;116Suppl I:I-139–I-143. [Google Scholar]
  12. Karkouti K, Duminda N, Wijeysundera, et al. Acute kidney injury after cardiac surgery: Focus on modifiable risk factors. Circulation. 2009;119:495–502. [CrossRef] [PubMed] [Google Scholar]
  13. Mehran R, Aymong ED, Nicolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol. 2004;44:1393–1399. [Google Scholar]
  14. Steroids In caRdiac Surgery Trial (SIRS Trial) ClinicalTrials.gov Identifier: NCT00427388. [Google Scholar]
  15. Jouan J, Golmard L, Benhamouda N, et al. Gene polymorphisms and cytokine plasma levels as predictive factors of complications after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2012;144:467–473. [CrossRef] [Google Scholar]
  16. Karkouti K, Duminda N, Wijeysundera DN, et al. Acute kidney injury after cardiac surgery: Focus on modifiable risk factors. Circulation. 2009;119:495–502. [CrossRef] [PubMed] [Google Scholar]
  17. Medalion B, Cohen H, Assali A, et al. The effect of cardiac angiography timing, contrast media dose, and preoperative renal function on acute renal failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2010;139:1488–1493. [Google Scholar]
  18. Marenzi G, Assenelli E, Campodonico J, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med. 2009;150:170–177. [CrossRef] [PubMed] [Google Scholar]
  19. Brown JR, Robb JF, Block CA, et al. Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv. 2010;3:346–350. [CrossRef] [PubMed] [Google Scholar]
  20. Kramer RS, Quinn RD, Groom RC, et al. Same admission cardiac catheterization and cardiac surgery: Is there an increased incidence of acute kidney injury? Ann Thorac Surg. 2010;90:1418–1424. [CrossRef] [Google Scholar]
  21. Ranucci M, Ballotta A, Agnelli B, Frigiola A, Menicanti L, Castelvecchio S. Acute kidney injury in patients undergoing cardiac surgery and coronary angiography on the same day. Ann Thorac Surg. 2013;95:513–519. [CrossRef] [Google Scholar]
  22. Hennessy SA, LaPar DJ, Stukenborg GJ, et al. Cardiac catheterization within 24 hours of valve surgery is significantly associated with acute renal failure. J Thorac Cardiovasc Surg. 2010;140:1011–1017. [CrossRef] [Google Scholar]
  23. Ranucci M, Romitti F, Isgro G, et al. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg. 2005;80:2213–2220. [CrossRef] [Google Scholar]
  24. de Somer F, Mulholland JW, Bryan MR, Aloisio T, Van Nooten GJ, Ranucci M. O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury: Time for a goal-directed perfusion management? Crit Care. 2011;15:R192. [CrossRef] [PubMed] [Google Scholar]
  25. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: Should current practice be changed? J Thorac Cardiovasc Surg. 2003;125:1438–1450. [CrossRef] [Google Scholar]
  26. Surgenor S, DeFoe GR, Fillinger MP, et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation. 2006;114Suppl I:I-43–I-48. [CrossRef] [Google Scholar]
  27. Loor G, Koch CG, Sabik JFIII, Li L, Blackstone EH. Implications and management of anemia in cardiac surgery: Current state of knowledge. J Thorac Cardiovasc Surg. 2012;144:538–546. [CrossRef] [Google Scholar]
  28. Shann KG, Likosky DS, Murkin JM, et al. An evidence based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg. 2006;132:283–290. [CrossRef] [Google Scholar]
  29. Cormack JC, Forest RJ, Groom RC, Morton JR. Size makes a difference: Use of a low prime cardiopulmonary bypass circuit and autologous priming in small adults. Perfusion. 2000;15:129–135. [CrossRef] [PubMed] [Google Scholar]
  30. McCusker K, Vijay V, DeBois W, Helm R, Sistino D. Mast System: A new condensed cardiopulmonary bypass circuit for adult surgery. Perfusion. 2002;16:447–452. [Google Scholar]
  31. Salmon A, Karajala-Subramanyam V, Kellum JA. The Kidney in Acute Heart Failure and Cardiogenic Shock in Critical Care Nephrology. Saunders Elsevier; 2009:992. [Google Scholar]
  32. Karkouti K, Wijeysundera DN, Yau TM, et al. Advance targeted transfusion in anemic cardiac surgical patients for kidney protection: An unblinded randomized pilot clinical trial. Anesthesiology. 2012; 116:613–621. [CrossRef] [PubMed] [Google Scholar]
  33. Vincent JL, Lelubre C. Preoperative transfusions to limit the deleterious effects of blood transfusions. Anesthesiology. 2012;116:513–514. [CrossRef] [PubMed] [Google Scholar]
  34. Tabata M, Khalpey Z, Pirundini PA, Byrne ML, Cohn LH, Rawn JD. Renoprotective effect of preoperative statins in coronary artery bypass grafting. Am J Cardiol. 2007;100:442–444. [CrossRef] [Google Scholar]
  35. Liakopoulos O, Choi Y, Haldenwang PL, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: A meta-analysis of over 30 000 patients. Eur Heart J. 2008;29:1548–1559. [CrossRef] [PubMed] [Google Scholar]
  36. de Azevedo JRA, de Azevedo RP, de Lucena LC, da Costa NNR, da Silva WS. Incidence of glycemic control on the incidence of acute kidney injury in critically ill patients: A comparison of two strategies using the RIFLE criteria. Clinics (Sao Paulo). 2010;65:769–773. [CrossRef] [PubMed] [Google Scholar]
  37. Mehta R. Glycemic control and critical illness: Is the kidney involved? J Am Soc Nephrol. 2007;18:2623–2627. [CrossRef] [PubMed] [Google Scholar]
  38. Lazar HL, McDonnell M, Chipkin SR, et al. Society of Thoracic Surgeons Practice Guideline Series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87:663–669. [CrossRef] [Google Scholar]
  39. Drenger B, Fontes ML, Miao Y, et al. Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: Effects on in-hospital morbidity and mortality. Circulation. 2012;126:261–269. [CrossRef] [PubMed] [Google Scholar]
  40. Ono M, Arnaoutakis GJ, Fine DM, et al. Blood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with acute kidney injury. Crit Care Med. 2013;41:464–471. [CrossRef] [PubMed] [Google Scholar]
  41. Tuman KJ, McCArthy RJ, O’Connor CJ, Holm WE, Ivankovich AD. Angiotensin converting enzyme inhibitors increase vasoconstrictor requirements after CPB. Anesth Analg. 1995;80:473–479. [CrossRef] [PubMed] [Google Scholar]
  42. Pigott DW, Nagele C, Westaby S, Evans RD. Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoconstrictor requirements. Br J Anaesth. 1999;83:715–720. [CrossRef] [Google Scholar]
  43. John R, Herzenberg AM. Renal toxicity of therapeutic drugs. J Clin Pathol. 2009;62:505–515. [CrossRef] [PubMed] [Google Scholar]
  44. Dixit M, Doan T, Kirshchner R, Dixit N. Significant acute kidney injury due to non-steroidal anti-inflammatory drugs: Inpatient setting. Pharmaceuticals (Ott). 2010;3:1279–1285. [CrossRef] [Google Scholar]
  45. Nielsen DV, Fedosova M, Hjortdal V, Jakobsen C. Is single-dose prophylactic gentamicin associated with acute kidney injury in patients undergoing cardiac surgery? A matched-pair analysis. J Thorac Cardiovasc Surg. 2014;148:1634–1639. [CrossRef] [Google Scholar]
  46. Dacey LJ, DeSimone J, Braxton JH, et al. Preoperative white blood cell count and mortality and morbidity after coronary artery bypass grafting. Ann Thorac Surg. 2003;76:760–764. [CrossRef] [Google Scholar]
  47. Maslow AD, Stearns G, Butala P, Schwartz CS, Gough J, Singh AK. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg. 2006;103:2–8. [CrossRef] [PubMed] [Google Scholar]
  48. Ozal E, Kuralay E, Yildirim V, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg. 2005;79:1615–1619. [CrossRef] [Google Scholar]
  49. Levin RL, DeGrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004;77:496–499. [CrossRef] [Google Scholar]
  50. Berry SA, Doll MC, McKinley KE, Casale AS, Bothe AJr. ProvenCare: Quality improvement model for designing highly reliable care in cardiac surgery. Qual Saf Health Care. 2009;18:360–368. [CrossRef] [PubMed] [Google Scholar]
  51. Kanji HD, Schulze CJ, Hervas-Malo M, et al. Difference between pre-operative and cardiopulmonary bypass mean arterial pressure is independently associated with early cardiac surgery-associated acute kidney injury. J Cardiothorac Surg. 2010;5:71. [CrossRef] [Google Scholar]
  52. Del Duca D, Iqbal S, Rahme E, Goldberg P, de Varennes B. Renal failure after cardiac surgery: Timing of cardiac catheterization and other perioperative risk factors. Ann Thorac Surg. 2007;84:1264–1271. [CrossRef] [Google Scholar]
  53. Palomba H, de Castro I, Neto AL, Lage S, Yu L. Acute kidney injury prediction following elective cardiac surgery. AKICS Score. Kidney Int. 2007;72:624–6231. [CrossRef] [Google Scholar]
  54. Society of Thoracic Surgeons (STS) Workforce on Evidence Based Surgery. Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. Ann Thorac Surg. 2011;91:944–982. [CrossRef] [Google Scholar]
  55. Belway D, Rubens FD, Wozny D, Henley B, Nathan HJ. Are we doing everything we can to conserve blood during bypass? A national survey. Perfusion. 2005;20:237–241. [CrossRef] [PubMed] [Google Scholar]
  56. Rubens FD, Boodhwani M, Mesana T, Wozny D, Wells G, Nathan HJ. The cardiotomy trial: a randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function. Circulation. 2007;116 Suppl:I89–I97. [CrossRef] [PubMed] [Google Scholar]
  57. Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm MA. Rational approach to perioperative fluid management. Anesthesiology. 2008;109:723–740. [CrossRef] [PubMed] [Google Scholar]
  58. Karkouti K, Beattie WS, Wijeysundera DN. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg. 2005;129:391–400. [CrossRef] [Google Scholar]
  59. Moody DM, Bell MA, Challa VR, Johnston WE, Prough DS. Brain microemboli during cardiac surgery or aortography. Ann Neurol. 1990;28:477–486. [CrossRef] [PubMed] [Google Scholar]
  60. Borger MA, Ivanov J, Weisel RD, Rao V, Peniston CM. Stroke during coronary bypass surgery: Principal role of cerebral macroemboli. Eur J Cardiothorac Surg. 2001;19:627–632. [CrossRef] [PubMed] [Google Scholar]
  61. Nicolosi AC, Aggarwal A, Almassi GH, Olinger GN. Intraoperative epiaortic ultrasound during cardiac surgery. J Card Surg. 1996;11:49–55. [CrossRef] [PubMed] [Google Scholar]
  62. Royse AG, Royse CF. Epiaortic ultrasound assessment of the aorta in cardiac surgery. Best Pract Res Clin Anaesthesiol. 2009;23:335–341. [CrossRef] [Google Scholar]
  63. Sylivris S, Calafiore P, Matalanis G, Rosalion A, Yuen HP. The intraoperative assessment of ascending aortic atheroma: Epiaortic imaging is superior to both transesophageal echocardiography and direct palpation. J Cardiothorac Vasc Anesth. 1997;11:704–707. [CrossRef] [Google Scholar]
  64. Schachner T, Nagele G, Kacani A, Laufer G, Bonatti J. Factors associated with presence of ascending aortic atherosclerosis in CABG patients. Ann Thorac Surg. 2004;78:2028–2032, discussion 2032. [CrossRef] [Google Scholar]
  65. DioDato CP, Likosky DS, DeFoe GR, et al. Cardiopulmonary bypass recommendations in adults: The northern New England experience. J Extra Corpor Technol. 2008;40:16–20. [Google Scholar]
  66. Ono M, Arnaoutakis GJ, Fine DM, et al. Blood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with acute kidney injury. Crit Care Med. 2013;41:464–471. [CrossRef] [PubMed] [Google Scholar]
  67. Newland RF, Tully PJ, Baker RA. Hyperthermic perfusion during cardiopulmonary bypass and postoperative temperature are independent predictors of acute kidney injury following cardiac surgery. Perfusion. 2013;28:223–231. [CrossRef] [PubMed] [Google Scholar]
  68. Santambrogio L, Leva C, Musazzi G, et al. Determination of pump flow rate during cardiopulmonary bypass in obese patients avoiding hemodilution. J Card Surg. 2009;24:245–249. [CrossRef] [Google Scholar]
  69. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: Pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;22:330–331. [CrossRef] [PubMed] [Google Scholar]
  70. Laffey JG, Boylan JF, Cheng DCH. The systemic inflammatory response to cardiac surgery. Anaesthesiology. 2002;97:215–252. [CrossRef] [PubMed] [Google Scholar]
  71. Frenette AJ, Bouchard J, Bernier P, et al. Albumin administration is associated with acute kidney injury in cardiac surgery: A propensity score analysis. Crit Care. 2014;18:602. [CrossRef] [PubMed] [Google Scholar]
  72. Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2011;2. [Google Scholar]
  73. Moran M, Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med. 1987;317:150–153. [CrossRef] [PubMed] [Google Scholar]
  74. Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308:1566–1572. [CrossRef] [PubMed] [Google Scholar]
  75. Guidet B, Soni N, Della Rocca G, et al. A balanced view of balanced solutions. Crit Care. 2010;14:325. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.